Dimensional Fund Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,603,705
Closed -$163M 3245
2025
Q4
$163M Sell
1,603,705
-585,159
-27% -$47M 0.03% 712
2025
Q3
$120M Buy
2,188,864
+239,313
+12% +$12M 0.03% 923
2025
Q2
$104M Buy
1,949,551
+348,345
+22% +$17.7M 0.02% 978
2025
Q1
$69.3M Buy
1,601,206
+632,021
+65% +$32M 0.02% 1260
2024
Q4
$54.5M Buy
969,185
+165,809
+21% +$10.3M 0.01% 1472
2024
Q3
$54.7M Sell
803,376
-199,408
-20% -$11.3M 0.01% 1454
2024
Q2
$42.4M Buy
1,002,784
+108,296
+12% +$5.96M 0.01% 1562
2024
Q1
$61.8M Buy
894,488
+198,946
+29% +$12.6M 0.02% 1316
2023
Q4
$51.5M Buy
695,542
+24,259
+4% +$1.59M 0.02% 1426
2023
Q3
$45.8M Sell
671,283
-24,510
-4% -$2.08M 0.02% 1402
2023
Q2
$65.3M Buy
695,793
+35,872
+5% +$2.8M 0.02% 1163
2023
Q1
$44.7M Buy
659,921
+109,445
+20% +$7.03M 0.02% 1409
2022
Q4
$27.3K Buy
550,476
+49,296
+10% +$2.01M 0.01% 1701
2022
Q3
$16.3M Buy
501,180
+3,925
+0.8% +$162K 0.01% 1932
2022
Q2
$19.6M Buy
497,255
+48,615
+11% +$2.6M 0.01% 1874
2022
Q1
$31.4M Buy
448,640
+53,454
+14% +$3.91M 0.01% 1721
2021
Q4
$30.8M Buy
395,186
+26,058
+7% +$2.3M 0.01% 1743
2021
Q3
$35.2M Buy
369,128
+16,908
+5% +$1.79M 0.01% 1677
2021
Q2
$43.8M Buy
352,220
+9,727
+3% +$1.16M 0.01% 1546
2021
Q1
$45.2M Buy
342,493
+3,233
+1% +$443K 0.01% 1525
2020
Q4
$45M Sell
339,260
-22,333
-6% -$2.7M 0.02% 1454
2020
Q3
$36.9M Buy
361,593
+47,454
+15% +$4.1M 0.02% 1446
2020
Q2
$27.3M Buy
314,139
+9,901
+3% +$791K 0.01% 1685
2020
Q1
$17.6M Buy
304,238
+27,338
+10% +$2.22M 0.01% 1830
2019
Q4
$25.6M Buy
276,900
+62,009
+29% +$5.45M 0.01% 1915
2019
Q3
$19.4M Sell
214,891
-13,890
-6% -$1.58M 0.01% 2036
2019
Q2
$27M Sell
228,781
-2,644
-1% -$266K 0.01% 1880
2019
Q1
$20M Sell
231,425
-14,172
-6% -$1.21M 0.01% 2049
2018
Q4
$15.5M Sell
245,597
-1,708
-0.7% -$117K 0.01% 2124
2018
Q3
$19.5M Buy
247,305
+6,186
+3% +$403K 0.01% 2134
2018
Q2
$14.4M Sell
241,119
-1,617
-0.7% -$87K 0.01% 2262
2018
Q1
$9.79M Buy
242,736
+17,783
+8% +$867K ﹤0.01% 2387
2017
Q4
$11.8M Buy
224,953
+21,808
+11% +$1.16M ﹤0.01% 2312
2017
Q3
$9.57M Buy
203,145
+91,794
+82% +$3.69M ﹤0.01% 2390
2017
Q2
$3.94M Buy
+111,351
New +$3.44M ﹤0.01% 2668
2015
Q1
Sell
-328,601
Closed -$9.02M 3352
2014
Q4
$9.02M Sell
328,601
-26,067
-7% -$634K 0.01% 2311
2014
Q3
$6.87M Hold
354,668
﹤0.01% 2401
2014
Q2
$6.04M Sell
354,668
-11,829
-3% -$163K ﹤0.01% 2489
2014
Q1
$5.19M Sell
366,497
-5,200
-1% -$70.2K ﹤0.01% 2543
2013
Q4
$4.34M Sell
371,697
-15,824
-4% -$182K ﹤0.01% 2620
2013
Q3
$4.58M Sell
387,521
-11,350
-3% -$146K ﹤0.01% 2584
2013
Q2
$5.55M Buy
+398,871
New +$4.33M 0.01% 2433

Other funds holding EXAS

Dimensional Fund Advisors's EXAS Position: Q1 2026 in Review

Dimensional Fund Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,603,705 shares — an estimated $163M sold.

Dimensional Fund Advisors first reported a position in EXAS in Q2 2013 and held it in 42 quarters. The position peaked at $163M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Dimensional Fund Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,603,705 Exact Sciences shares in Q1 2026, an estimated $163M.
  • Dimensional Fund Advisors first reported a position in Exact Sciences in Q2 2013 and held it in 42 quarters.
  • Dimensional Fund Advisors's Exact Sciences position peaked at $163M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.